Skip to content

GYRE THERAPEUTICS, INC.

GYRE · XNAS

CIK 1124105fmd_05540E69XQFAP0H1K9E1R4EJ2FManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading